Twenty20, a Marina Del Rey, Calif.-based provider of crowdsourced real-world images, raised $8m in Series A funding. The round was...
Read More →Unchained Labs, a Pleasanton, CA-based startup life sciences tools company, raised $25m in Series A Financing. The round was led...
Read More →ClusterHQ, the company behind Flocker, the open-source project for containerizing stateful services, raised $12m Series A funding. The round was...
Read More →Beckon, a San Mateo, CA-based marketing intelligence software provider, raised $13m in Series B funding. The round was led by...
Read More →CytomX, a South San Francisco, CA-based biotechnology company developing therapeutics for the treatment of cancer, raised $20m in Series C financing...
Read More →UNIFi Software, a San Francisco, CA-based provider of a comprehensive data integration solution for the enterprise, raised $4.45m in seed...
Read More →Viewbix, a Tel Aviv, Israel-based video engagement platform, closed $3m in funding. Backers included 2M Companies, Canaan Partners and Longfellow...
Read More →CompStak, a New York, NY-based marketplace for commercial real estate data, closed a $4.4m funding round. The round was led...
Read More →Orchard Platform, a NYC-based provider of an investment and analytics platform focused on the global marketplace lending market, raised $12m...
Read More →Canaan Partners, a Menlo Park-based venture capital firm, raised $675m for its tenth fund. Canaan X, which brought the total...
Read More →AdNear, a Singapore-based mobile advertising platform, raised $19m in Series BÂ funding. Backers included Telstra Ventures and Global Brain and existing...
Read More →Civitas Therapeutics, Inc., a Chelsea MA-based biopharmaceutical company developing and commercializing therapeutics using its proprietary technology, completed a $55m Series...
Read More →Aldea Pharmaceuticals, a Redwood City, CA-based developer of novel therapeutics to treat aldehyde metabolism disorders, closed a $24m Series B...
Read More →Dermira, a Redwood City, Calif-based specialty biopharmaceutical company focused on developing medical dermatology products, today completed a $51m Series C...
Read More →
